Jie Lun Zhu
Fondateur chez Vivere Lifesciences Acquisition Corp.
Postes actifs de Jie Lun Zhu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Vivere Lifesciences Acquisition Corp.
 Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Directeur/Membre du Conseil | 08/02/2022 | - |
| Directeur en chef des Investissements | 08/02/2022 | - | |
| Fondateur | 08/02/2022 | - |
Historique de carrière de Jie Lun Zhu
Anciens postes connus de Jie Lun Zhu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Jefferies Hong Kong Ltd.
 Jefferies Hong Kong Ltd. Investment Banks/BrokersFinance Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients. | Corporate Officer/Principal | 01/12/2015 | 01/07/2018 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Directeur Financier/CFO | 01/08/2018 | - |
Formation de Jie Lun Zhu
| Harvard Business School | Masters Business Admin |
| Wesleyan University | Undergraduate Degree |
Statistiques
Internationale
| Hong Kong | 3 |
| Etats-Unis | 3 |
| Chine | 2 |
Opérationnelle
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Finance | 3 |
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
Vivere Lifesciences Acquisition Corp.
Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Finance |
Jefferies Hong Kong Ltd.
Jefferies Hong Kong Ltd. Investment Banks/BrokersFinance Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients. | Finance |
- Bourse
- Insiders
- Jie Lun Zhu
- Expérience
